JPRN-jRCT1080222138未知Unknown
Post-marketing surveillance of donepezil hydrochloride -Investigation of the factors that affect Aricept medication persistence rate and the safety and efficacy in patients with Alzheimer's Disease in clinical practice (Study ART08T)
适应症
试验速览
- 阶段
- Unknown
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients diagnosed as Alzheimer's Disease and administered Aricept for the first time.
排除标准
- •Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.
研究者
相似试验
未知
Unknown
Post-marketing surveillance of donepezil hydrochloride -Investigation of the clinical safety and effectiveness in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080221997Eisai Co., Ltd.1,000
未知
Unknown
Post-marketing surveillance of donepezil hydrochloride Dementia with Lewy bodies/long-term administratioDementia with Lewy bodiesJPRN-jRCT1080222854Eisai Co., Ltd.500
未知
Unknown
Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080222139Eisai Co., Ltd.5,000
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseAlzheimer's DiseaseNCT01251718Eisai Co., Ltd.894
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's DiseaseAlzheimer's DeseaseNCT02162251Eisai Co., Ltd.3,482